HLA-DRB1 and myeloid sarcoma: For example, in the Wellcome Trust Case Control Consortium (WTCCC) dataset [13], the odds ratio (OR) of MS for individuals possessing one or more of these alleles is highly significant–for HLA-DRB1*15:01 (OR = 3.